The Monoamine Oxidase-B Inhibitor Selegiline Does Not Affect 18 F-Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series

The Monoamine Oxidase-B Inhibitor Selegiline Does Not Affect ¹⁸ F-Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series

Mov Disord. 2023 Apr;38(4):705-707. doi: 10.1002/mds.29328. Epub 2023 Jan 27.

¹ Department of Neurology, National Research Center for Aging and Medicine, National Center for Neurological Disorders, and State Key Laboratory of Medical Neurobiology, Huashan Hospital, Fudan University, Shanghai, China.
² Department of Nuclear Medicine & PET Center, National Center for Neurological Disorders, and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
³ APRINOIA Therapeutics, Suzhou, China.

No abstract available

Keywords: 18F-Florzolotau; monoamine oxidase B; positron emission tomography; selegiline; tau.